106
Views
7
CrossRef citations to date
0
Altmetric
Original Research

Serum endocan levels in patients with stable COPD

, &
Pages 3367-3372 | Published online: 15 Oct 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Jing An, Ting Yang, Jiajia Dong, Zenglin Liao, Chun Wan, Yongchun Shen & Lei Chen. (2021) Identifying miRNA Modules and Related Pathways of Chronic Obstructive Pulmonary Disease Associated Emphysema by Weighted Gene Co-Expression Network Analysis. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3119-3130.
Read now
Yanqiu Wu, Jiangyue Qin, Junyun He, Yongchun Shen, Hao Wang, Yanping Li, Qianglin Zeng, Jiajia Dong, Yunfei An, Shuguang Xiong, Mei Feng & Fuqiang Wen. (2020) Serum Endostatin Is a Novel Marker for COPD Associated with Lower Lung Function, Exacerbation and Systemic Inflammation. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 397-407.
Read now

Articles from other publishers (5)

Robin Caird, Michael Williamson, Azeez Yusuf, Debananda Gogoi, Michelle Casey, Noel G. McElvaney & Emer P. Reeves. (2022) Targeting of Glycosaminoglycans in Genetic and Inflammatory Airway Disease. International Journal of Molecular Sciences 23:12, pages 6400.
Crossref
Paige Amendum, Shaukat Khan, Seiji Yamaguchi, Hironori Kobayashi, Yasuhiko Ago, Yasuyuki Suzuki, Betul Celik, Estera Rintz, Jobayer Hossain, Wendi Xiao & Shunji Tomatsu. (2021) Glycosaminoglycans as Biomarkers for Mucopolysaccharidoses and Other Disorders. Diagnostics 11:9, pages 1563.
Crossref
Erdal İn, Mutlu Kuluöztürk, Teyfik Turgut, Ayşegül Altıntop Geçkil & Nevin İlhan. (2020) Endocan as a potential biomarker of disease severity and exacerbations in COPD. The Clinical Respiratory Journal 15:4, pages 445-453.
Crossref
雪 梁. (2021) <i>ESM1</i>: A New Target for Cancer Therapy. Pharmacy Information 10:03, pages 121-128.
Crossref
João Bessa, António Albino-Teixeira, Marta Reina-Couto & Teresa Sousa. (2020) Endocan: A novel biomarker for risk stratification, prognosis and therapeutic monitoring in human cardiovascular and renal diseases. Clinica Chimica Acta 509, pages 310-335.
Crossref